Cardiorenal Syndrome

Recovery of Worsening Renal Func on A er Acute Heart Failure

by Prateek Chopra | June 2, 2026 | Cardiology Conferences | ESC-HF 2026 Worsening renal function (WRF) frequently occurs during hospitalization for acute decompensated heart failure (ADHF), although its prognostic significance remains controversial because transient creatinine increases may reflect effective decongestion or initiation of guideline-directed medical therapy rather than irreversible renal injury. This study evaluated the rate of WRF recovery after […]

Recovery of Worsening Renal Func on A er Acute Heart Failure Read Post »

Leave a Comment / ESC-HF Day 4 / bluetree.healthcare@gmail.com / July 30, 2026 / Acute Decompensated Heart Failure (ADHF), Cardiorenal Syndrome, Heart Failure Prognosis, Renal Function Recovery, Worsening Renal Function (WRF)

Efficacy and Safety of Sacubitril/Valsartan in the Management of Heart Failure with Reduced Ejection on Fraction on and Chronic Kidney Disease: A Systema c Review and Meta-Analysis

by Prateek Chopra | May 23, 2026 | Cardiology Conferences | ESC-HF 2026 Patients with heart failure with reduced ejection fraction (HFrEF) and advanced chronic kidney disease (CKD) have limited therapeutic options and poor prognosis. Although sacubitril/valsartan has improved outcomes in HFrEF, major trials excluded patients with CKD stage 4 or higher, leaving uncertainty regarding its efficacy and safety in this

Efficacy and Safety of Sacubitril/Valsartan in the Management of Heart Failure with Reduced Ejection on Fraction on and Chronic Kidney Disease: A Systema c Review and Meta-Analysis Read Post »

Leave a Comment / ESC-HF Day 2 / bluetree.healthcare@gmail.com / July 30, 2026 / Cardiorenal Syndrome, Chronic Kidney Disease (CKD), Heart Failure Hospitalization, Heart Failure with Reduced Ejection Fraction (HFrEF), Sacubitril/Valsartan (ARNI)

Type 2 Diabetes and Chronic Kidney Disease Combina ons in Heart Failure Acrossthe Ejec on Frac on Spectrum: Clinical Associa ons, Medica on Use, andCause-Specific Outcomes

by Prateek Chopra | May 18, 2026 | Cardiology Conferences | ESC-HF 2026 Type 2 Diabetes Mellitus (T2DM) and Chronic Kidney Disease (CKD) frequently coexist with Heart Failure (HF), substantially increasing the risks of mortality and hospitalization for HF (HHF). Several HF therapies have demonstrated cardiorenal benefits in patients with CKD and/or T2DM; however, real-world evidence suggests that these therapies remain

Type 2 Diabetes and Chronic Kidney Disease Combina ons in Heart Failure Acrossthe Ejec on Frac on Spectrum: Clinical Associa ons, Medica on Use, andCause-Specific Outcomes Read Post »

Leave a Comment / ESC-HF Day 1 / bluetree.healthcare@gmail.com / July 29, 2026 / Cardiorenal Syndrome, Guideline-Directed Medical Therapy (GDMT), Heart Failure and Chronic Kidney Disease (CKD), Heart Failure Outcomes, Type 2 Diabetes (T2DM)